We are live on ! Find out more
LPCN icon

Lipocine

46 hedge funds and large institutions have $4.85M invested in Lipocine in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,000% more call options, than puts

Call options by funds: $496K | Put options by funds: $16K

0% more funds holding

Funds holding: 4646 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

0.07% less ownership

Funds ownership: 0.79%0.72% (-0.07%)

49% less capital invested

Capital invested by funds: $9.54M → $4.85M (-$4.69M)

60% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 10

Holders
46
Holders Change
Holders Change %
0%
% of All Funds
0.79%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
4
Reduced
10
Closed
7
Calls
$496K
Puts
$16K
Net Calls
+$480K
Net Calls Change
-$412K
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$16K +$1.92K +172 +9%
Jane Street
27
Jane Street
New York
$14K +$3.06K +274 +17%
MFG
28
Merit Financial Group
Georgia
$13K
EWA
29
EP Wealth Advisors
California
$12K +$17.5K +1,567 New
MSAM
30
Moloney Securities Asset Management
Missouri
$10K
PMFA
31
Plante Moran Financial Advisors
Michigan
$8K
KPWS
32
Kestra Private Wealth Services
Texas
$7K +$9.5K +851 New
Mariner
33
Mariner
Kansas
$6K +$8.98K +804 New
Creative Planning
34
Creative Planning
Kansas
$5K
CG
35
Cutler Group
California
$5K
SCA
36
Snowden Capital Advisors
New York
$5K
TRCT
37
Tower Research Capital (TRC)
New York
$4K +$6.5K +582 New
BFEC
38
Benjamin F. Edwards & Company
Missouri
$1K
JP Morgan Chase
39
JP Morgan Chase
New York
$1K
Osaic Holdings
40
Osaic Holdings
Arizona
$1K
TC
41
Truvestments Capital
Florida
$1K
Marshall Wace
42
Marshall Wace
United Kingdom
-$353K -25,921 Closed
B
43
Bailard
California
-$60K -4,376 Closed
CA
44
Carson Advisory
Georgia
-$42K -3,059 Closed
Goldman Sachs
45
Goldman Sachs
New York
-$21K -1,527 Closed
GSC
46
Ground Swell Capital
South Carolina
-$16K -1,185 Closed
RJA
47
Raymond James & Associates
Florida
-$9K -641 Closed
Wells Fargo
48
Wells Fargo
California
-$1.97K -176 -83%
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
+$134 +12 New

LPCN Hedge Fund Activity: Q3 2022 in Review

46 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q3 2022, worth a combined $4.85M — down 49% from $9.54M a quarter earlier.

Fund positioning in LPCN was balanced in Q3 2022: 7 funds opened new positions, 7 closed out, 4 added to existing stakes and 10 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $194K. The largest seller was Marshall Wace, exiting entirely with an estimated $353K sold.

  • 46 institutional investors held Lipocine (LPCN) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $4.85M of Lipocine stock for Q3 2022, down 49% quarter-over-quarter.
  • 7 funds opened new Lipocine positions in Q3 2022 and 7 closed out, a net change of 0 holders.
  • The largest Lipocine buyer in Q3 2022 was Citadel Advisors, an estimated $194K added.
  • The largest Lipocine seller in Q3 2022 was Marshall Wace, an estimated $353K sold.

Based on aggregated 13F filings for Q3 2022.